Mice showed a reduction in lung inflammation caused by exposure to cigarette smoke after they were treated with an agent that blocks the activity of a protein called granulocyte macrophage-colony stimulating factor, Australian scientists found. They said the finding might lead to additional ways of treating chronic pulmonary obstructive disease and other conditions related to smoking.

Full Story:

Related Summaries